Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Genomic amplicons target vesicle recycling in breast cancer
Gordon B. Mills, … , Yosef Yarden, Jim C. Norman
Gordon B. Mills, … , Yosef Yarden, Jim C. Norman
Published July 20, 2009
Citation Information: J Clin Invest. 2009;119(8):2123-2127. https://doi.org/10.1172/JCI40256.
View: Text | PDF
Commentary

Genomic amplicons target vesicle recycling in breast cancer

  • Text
  • PDF
Abstract

Aberrant endocytosis, vesicle targeting, and receptor recycling represent emerging hallmarks of cancer. In this issue of the JCI, Zhang and colleagues demonstrate that RAB-coupling protein (RCP; also known as RAB11FIP1) is a “driver” of the 8p11–12 amplicon in human breast cancer and mouse xenograft models of mammary carcinogenesis (see the related article beginning on page 2171). Their finding that RAB GTPase function enables genomic amplification to confer aggressiveness to mammary tumors adds significantly to the body of evidence supporting pivotal roles for receptor trafficking in the proliferation and metastasis of cancer.

Authors

Gordon B. Mills, Igor Jurisica, Yosef Yarden, Jim C. Norman

×

Total citations by year

Year: 2023 2022 2021 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Total
Citations: 1 1 1 2 2 2 2 1 2 4 3 1 1 23
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (23)

Title and authors Publication Year
microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin β1 recycling on the membrane.
Bhattacharya S, Sarker S, Das S, Ahir M, Chattopadhyay S, Ghosh S, Adhikary A
Apoptosis : an international journal on programmed cell death 2023
TP53 mutations upregulate RCP expression via Sp1/3 to drive lung cancer progression.
Wang C, Zhang S, Ma B, Fu Y, Luo Y
Oncogene 2022
D-Propranolol Impairs EGFR Trafficking and Destabilizes Mutant p53 Counteracting AKT Signaling and Tumor Malignancy
J Barra, J Cerda-Infante, L Sandoval, P Gajardo-Meneses, JF Henriquez, M Labarca, C Metz, J Venegas, C Retamal, C Oyanadel, J Cancino, A Soza, MA Cuello, JC Roa, VP Montecinos, A Gonzalez
Cancers 2021
RCP induces FAK phosphorylation and ovarian cancer cell invasion with inhibition by curcumin
SR Choe, YN Kim, CG Park, KH Cho, DY Cho, HY Lee
Experimental & molecular medicine 2018
Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin
BY Jeong, KH Cho, KJ Jeong, YY Park, JM Kim, SY Rha, CG Park, GB Mills, JH Cheong, HY Lee
Experimental & molecular medicine 2018
Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion
C Gundry, S Marco, E Rainero, B Miller, E Dornier, L Mitchell, PT Caswell, AD Campbell, A Hogeweg, OJ Sansom, JP Morton, JC Norman
Nature Communications 2017
Emerging functions of the EGFR in cancer
S Sigismund, D Avanzato, L Lanzetti
Molecular Oncology 2017
RCP induces Slug expression and cancer cell invasion by stabilizing β1 integrin
MH Hwang, KH Cho, KJ Jeong, YY Park, JM Kim, SL Yu, CG Park, GB Mills, HY Lee
Oncogene 2016
Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT
S Mitra, L Federico, W Zhao, J Dennison, TR Sarkar, F Zhang, V Takiar, KW Cheng, S Mani, JS Lee, GB Mills
Oncotarget 2016
Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis
SD da Silva, FA Marchi, B Xu, K Bijian, F Alobaid, A Mlynarek, SR Rogatto, M Hier, LP Kowalski, MA Alaoui-Jamali
Oncotarget 2015
Integrin traffic - the update
ND Franceschi, H Hamidi, J Alanko, P Sahgal, J Ivaska
Journal of cell science 2015
SYK allelic loss and the role of Syk-regulated genes in breast cancer survival
J Blancato, A Graves, B Rashidi, M Moroni, L Tchobe, M Ozdemirli, B Kallakury, KH Makambi, C Marian, SC Mueller
PloS one 2014
FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance
IA Ivanova, JF Vermeulen, C Ercan, JM Houthuijzen, FA Saig, EJ Vlug, E der Wall, PJ van Diest, M Vooijs, PW Derksen
Oncogene 2013
Endocytosis and Cancer
I Mellman, Y Yarden
Cold Spring Harbor perspectives in biology 2013
Increased expression of Rab coupling protein in squamous cell carcinoma of the head and neck and its clinical significance
Y Dai, Y Liu, D Huang, C Yu, G Cai, L Pi, C Ren, GZ Chen, Y Tian, X Zhang
Oncology Letters 2012
Rab25 in cancer: a brief update
S Mitra, KW Cheng, GB Mills
Biochemical Society Transactions 2012
Myoferlin Depletion in Breast Cancer Cells Promotes Mesenchymal to Epithelial Shape Change and Stalls Invasion
R Li, WE 4th, C Mihai, LI Volakis, S Ghadiali, DA Kniss
PloS one 2012
Regulation of cholesterol biosynthesis and cancer signaling
A Gorin, L Gabitova, I Astsaturov
Current Opinion in Pharmacology 2012
Rab GTPases implicated in inherited and acquired disorders
S Mitra, KW Cheng, GB Mills
Seminars in Cell & Developmental Biology 2011
Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression
F Pareja, DA Ferraro, C Rubin, H Cohen-Dvashi, F Zhang, S Aulmann, N Ben-Chetrit, G Pines, R Navon, N Crosetto, W Köstler, S Carvalho, S Lavi, F Schmitt, I Dikic, Z Yakhini, P Sinn, GB Mills, Y Yarden
Oncogene 2011
Integrative computational biology for cancer research
K Fortney, I Jurisica
Human Genetics 2011
beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression
L Huck, SM Pontier, DM Zuo, WJ Muller
Proceedings of the National Academy of Sciences 2010
Integrins: masters and slaves of endocytic transport
PT Caswell, S Vadrevu, JC Norman
Nature Reviews Molecular Cell Biology 2009

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts